$2.43 +0.04 (%) Targacept Inc - NASDAQ

Apr. 24, 2015 | 04:00 PM

Partner Headlines

  1. Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis

    Benzinga | Apr. 16, 2015 | 08:34AM EST
  2. Stocks Hitting 52-Week Lows

    Benzinga | Jul. 29, 2014 | 10:26AM EST
  3. Morning Market Losers

    Benzinga | Jul. 29, 2014 | 09:54AM EST
  4. UPDATE: Targacept Announces will Discontinue TC-5214 Program, Cites Mixed Results

    Benzinga | Jul. 28, 2014 | 16:35PM EST
  5. Feuerstein Tweet Shaved 16% From Targacept; Key Drug Fails Phase IIb Trial

    Benzinga | Jul. 14, 2014 | 16:22PM EST
  6. UPDATE: Targacept Official Release Confirms Phase 2b Trial in TC-1734 Did Not Show Superiority to Donepezil

    Benzinga | Jul. 14, 2014 | 15:07PM EST
  7. Weekly Three-Year Low Highlights: ESIO, VJET, TRGT, ZX

    GuruFocus | May. 13, 2014 | 11:20AM EST
  8. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 17, 2013 | 10:11AM EST
  9. Morning Market Losers

    Benzinga | Dec. 17, 2013 | 10:01AM EST
  10. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 17, 2013 | 08:28AM EST
  11. Targacept Announces Negative Top-Line Results from Phase 2b Trial of TC-5619 in Schizophrenia

    Benzinga | Dec. 16, 2013 | 16:06PM EST
  12. Targacept Says Hill Named CEO

    Benzinga | Nov. 15, 2012 | 01:56AM EST
  13. Targacept Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 10:06AM EST
  14. Targacept Scientists to Present at Neuroscience 2012

    Benzinga | Oct. 11, 2012 | 03:01AM EST
  15. Targacept to Perform Workforce Reductions That Will Affect 38% of Employees; To Close Laboratory Operations At End of 2012

    Benzinga | Oct. 8, 2012 | 03:12AM EST
  16. Morning Market Losers

    Benzinga | Sep. 17, 2012 | 03:56AM EST
  17. Targacept Says Top-Line Results from Phase 2 Trial of TC-5619 Didn't Meet Primary Outcome Measure

    Benzinga | Sep. 17, 2012 | 03:16AM EST
  18. Targacept Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 11:26AM EST
  19. Why Should You Invest Only in High-Quality Companies?

    GuruFocus | Jun. 13, 2012 | 10:39AM EST
  20. AstraZeneca

    IBD | Mar. 20, 2012 | 12:38PM EST
  21. Seth Klarman Latest Portfolio: Buys IDIX, NG, ANV, Sells PDLI, ALR, BBEP

    GuruFocus | Feb. 10, 2012 | 10:19AM EST
  22. Notable Put Options Activity in Targacept

    Benzinga | Jan. 30, 2012 | 06:21AM EST
  23. Value Idea Contest Winners Announcement

    GuruFocus | Jan. 17, 2012 | 01:55AM EST
  24. Options Players Zero In on Targacept Puts

    SchaeffersResearch | Dec. 23, 2011 | 12:52PM EST
  25. Four Stocks to Fit in a Basket of Negative Enterprise Value with Certain Profitability

    GuruFocus | Dec. 23, 2011 | 05:36AM EST
  26. Four Stocks to Fit in a Basket of Negative Enterprise Value with Certain Profitability: GENC, ...

    GuruFocus | Dec. 23, 2011 | 05:36AM EST
  27. Seth Klarman's New Purchase Targacept (TRGT) Is Now a Net-Net

    GuruFocus | Dec. 21, 2011 | 06:23AM EST
  28. Seth Klarman's New Purchase Targacept Is Now a Net-Net

    GuruFocus | Dec. 21, 2011 | 06:23AM EST
  29. Stocks Finish Sharply Higher as Euro-Zone Worries Ease

    MarketIntelligenceCenter | Dec. 20, 2011 | 16:19PM EST
  30. Global Hunter Downgrades Targacept to Neutral, Removes PT

    Benzinga | Dec. 20, 2011 | 05:35AM EST
  31. Deutsche Bank Reiterates Hold, $12 PT On Targacept

    Benzinga | Dec. 20, 2011 | 04:21AM EST
  32. Benzinga's Top Pre-Market Losers

    Benzinga | Dec. 20, 2011 | 01:20AM EST
  33. Analysis of Targacept: Seth Klarman's New Purchase

    GuruFocus | Dec. 16, 2011 | 09:47AM EST
  34. Notable Call Options Activity in Targacept

    Benzinga | Dec. 15, 2011 | 04:55AM EST
  35. Should We Follow Seth Klarman on the Purchase of Targacept?

    GuruFocus | Dec. 13, 2011 | 00:32AM EST
  36. Seth Klarman Buys 16.92% Stake in Targacept (TRGT) After Stock Drops 60%

    GuruFocus | Dec. 12, 2011 | 11:30AM EST
  37. Notable Call Options Activity in Targacept

    Benzinga | Dec. 12, 2011 | 03:12AM EST
  38. Despite Dismal Drug Data, Out-of-the-Money Calls Heat Up on Targacept

    SchaeffersResearch | Nov. 8, 2011 | 12:34PM EST
Trading Center